Report Detail

Request for Sample of this report

Pharma & Healthcare Global Traveler's Diarrhea Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2790957
    • |
  • 30 July, 2019
    • |
  • Global
    • |
  • 116 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.

Scope of the Report:
Traveler’s diarrhea is the leading cause of illness among international travelers to developing countries. Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of this disease. Among the estimated 65 million travelers from industrialized countries to high-risk areas in the developing world, as many as 50% may experience at least one TD episode during their journey. ETEC is usually responsible for 22-60% of all TD cases in both civilian and military groups or about 7-18 million cases per year. ETEC is also a major cause of diarrheal disease in children living in countries endemic for ETEC, leading to over 400 million diarrheal episodes and approximately 300,000 deaths each year.
The classification of Traveler’s Diarrhea Therapeutics includes Immunization, Non-antibiotic Agents, Antibiotics, Anti-Motility Agents, Other. And the proportion of Non-antibiotic Agents in 2017 is about 36%, and And the proportion of Anti-Motility Agents in 2017 is about 20%.
The worldwide market for Traveler's Diarrhea Therapeutics is expected to grow at a CAGR of roughly 7.1% over the next five years, will reach 890 million US$ in 2024, from 630 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Traveler's Diarrhea Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Other

Market Segment by Applications, can be divided into
Adult Traveler's Diarrhea
Children Traveler's Diarrhea

There are 15 Chapters to deeply display the global Traveler's Diarrhea Therapeutics market.
Chapter 1, to describe Traveler's Diarrhea Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Traveler's Diarrhea Therapeutics, with sales, revenue, and price of Traveler's Diarrhea Therapeutics, in 2017 and 2018;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Traveler's Diarrhea Therapeutics, for each region, from 2014 to 2019;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2014 to 2019;
Chapter 12, Traveler's Diarrhea Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
Chapter 13, 14 and 15, to describe Traveler's Diarrhea Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

    1 Market Overview

    • 1.1 Traveler's Diarrhea Therapeutics Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Immunization
      • 1.2.2 Non-antibiotic Agents
      • 1.2.3 Antibiotics
      • 1.2.4 Anti-Motility Agents
      • 1.2.5 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Adult Traveler's Diarrhea
      • 1.3.2 Children Traveler's Diarrhea
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Nigeria Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Salix Pharmaceuticals
      • 2.1.1 Business Overview
      • 2.1.2 Traveler's Diarrhea Therapeutics Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 P&G
      • 2.2.1 Business Overview
      • 2.2.2 Traveler's Diarrhea Therapeutics Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Johnson & Johnson
      • 2.3.1 Business Overview
      • 2.3.2 Traveler's Diarrhea Therapeutics Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Otsuka Pharma
      • 2.4.1 Business Overview
      • 2.4.2 Traveler's Diarrhea Therapeutics Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Valneva
      • 2.5.1 Business Overview
      • 2.5.2 Traveler's Diarrhea Therapeutics Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Shanghai United Cell
      • 2.6.1 Business Overview
      • 2.6.2 Traveler's Diarrhea Therapeutics Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 PaxVax
      • 2.7.1 Business Overview
      • 2.7.2 Traveler's Diarrhea Therapeutics Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Livzon
      • 2.8.1 Business Overview
      • 2.8.2 Traveler's Diarrhea Therapeutics Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Immuron
      • 2.9.1 Business Overview
      • 2.9.2 Traveler's Diarrhea Therapeutics Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Traveler's Diarrhea Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Traveler's Diarrhea Therapeutics Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Traveler's Diarrhea Therapeutics Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Traveler's Diarrhea Therapeutics Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Traveler's Diarrhea Therapeutics Market Analysis by Regions

    • 4.1 Global Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Traveler's Diarrhea Therapeutics Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 4.3 Europe Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 4.5 South America Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)

    5 North America Traveler's Diarrhea Therapeutics by Countries

    • 5.1 North America Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Traveler's Diarrhea Therapeutics Sales and Market Share by Countries (2014-2019)
      • 5.1.2 North America Traveler's Diarrhea Therapeutics Revenue and Market Share by Countries (2014-2019)
    • 5.2 United States Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 5.3 Canada Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)

    6 Europe Traveler's Diarrhea Therapeutics by Countries

    • 6.1 Europe Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Traveler's Diarrhea Therapeutics Sales and Market Share by Countries (2014-2019)
      • 6.1.2 Europe Traveler's Diarrhea Therapeutics Revenue and Market Share by Countries (2014-2019)
    • 6.2 Germany Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 6.3 UK Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 6.4 France Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 6.5 Russia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 6.6 Italy Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Traveler's Diarrhea Therapeutics by Countries

    • 7.1 Asia-Pacific Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Traveler's Diarrhea Therapeutics Sales and Market Share by Countries (2014-2019)
      • 7.1.2 Asia-Pacific Traveler's Diarrhea Therapeutics Revenue and Market Share by Countries (2014-2019)
    • 7.2 China Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 7.3 Japan Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 7.4 Korea Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 7.5 India Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)

    8 South America Traveler's Diarrhea Therapeutics by Countries

    • 8.1 South America Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Traveler's Diarrhea Therapeutics Sales and Market Share by Countries (2014-2019)
      • 8.1.2 South America Traveler's Diarrhea Therapeutics Revenue and Market Share by Countries (2014-2019)
    • 8.2 Brazil Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Traveler's Diarrhea Therapeutics by Countries

    • 9.1 Middle East and Africa Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Traveler's Diarrhea Therapeutics Sales and Market Share by Countries (2014-2019)
      • 9.1.2 Middle East and Africa Traveler's Diarrhea Therapeutics Revenue and Market Share by Countries (2014-2019)
    • 9.2 Saudi Arabia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 9.3 UAE Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)

    10 Global Traveler's Diarrhea Therapeutics Market Segment by Type

    • 10.1 Global Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Traveler's Diarrhea Therapeutics Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Type (2014-2019)
    • 10.2 Immunization Sales Growth and Price
      • 10.2.1 Global Immunization Sales Growth (2014-2019)
      • 10.2.2 Global Immunization Price (2014-2019)
    • 10.3 Non-antibiotic Agents Sales Growth and Price
      • 10.3.1 Global Non-antibiotic Agents Sales Growth (2014-2019)
      • 10.3.2 Global Non-antibiotic Agents Price (2014-2019)
    • 10.4 Antibiotics Sales Growth and Price
      • 10.4.1 Global Antibiotics Sales Growth (2014-2019)
      • 10.4.2 Global Antibiotics Price (2014-2019)
    • 10.5 Anti-Motility Agents Sales Growth and Price
      • 10.5.1 Global Anti-Motility Agents Sales Growth (2014-2019)
      • 10.5.2 Global Anti-Motility Agents Price (2014-2019)
    • 10.6 Other Sales Growth and Price
      • 10.6.1 Global Other Sales Growth (2014-2019)
      • 10.6.2 Global Other Price (2014-2019)

    11 Global Traveler's Diarrhea Therapeutics Market Segment by Application

    • 11.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2014-2019)
    • 11.2 Adult Traveler's Diarrhea Sales Growth (2014-2019)
    • 11.3 Children Traveler's Diarrhea Sales Growth (2014-2019)

    12 Traveler's Diarrhea Therapeutics Market Forecast (2019-2024)

    • 12.1 Global Traveler's Diarrhea Therapeutics Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Traveler's Diarrhea Therapeutics Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Traveler's Diarrhea Therapeutics Market Forecast (2019-2024)
      • 12.2.2 Europe Traveler's Diarrhea Therapeutics Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Traveler's Diarrhea Therapeutics Market Forecast (2019-2024)
      • 12.2.4 South America Traveler's Diarrhea Therapeutics Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Traveler's Diarrhea Therapeutics Market Forecast (2019-2024)
    • 12.3 Traveler's Diarrhea Therapeutics Market Forecast by Type (2019-2024)
      • 12.3.1 Global Traveler's Diarrhea Therapeutics Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Traveler's Diarrhea Therapeutics Market Share Forecast by Type (2019-2024)
    • 12.4 Traveler's Diarrhea Therapeutics Market Forecast by Application (2019-2024)
      • 12.4.1 Global Traveler's Diarrhea Therapeutics Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Traveler's Diarrhea Therapeutics Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Traveler's Diarrhea Therapeutics . Industry analysis & Market Report on Traveler's Diarrhea Therapeutics is a syndicated market report, published as Global Traveler's Diarrhea Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Traveler's Diarrhea Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,777.04
      		4,165.56
      		5,554.08
      		3,250.32
      		4,875.48
      		6,500.64
      		543,819.60
      		815,729.40
      		1,087,639.20
      		290,545.20
      		435,817.80
      		581,090.40
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo